Lentiviral Vectors Market 2022: Growing Application in T-Cell Engineering and Bioprocessing

Lentiviral vectors are gene delivery mechanisms that are produced from the lentivirus of the human immunodeficiency virus type 1 (HIV-1). These vectors are mainly incompetent for replication, and hence, regarded as generally safe. Yet, they can successfully integrate into the genomic DNA of a wide variety of dividing and non-dividing mammalian cell types.

Request For Free Sample Report of "Lentiviral Vectors Market"@ https://www.persistencemarketresearch.com/samples/33074

With recorded sales of US$ 127.6 Mn in 2021, the global lentiviral vectors market is predicted to experience high growth over the years ahead, owing to high product adoption globally. Demand for lentiviral vectors is estimated to surge at a CAGR of 11.4 % from 2022 to 2032.

Many genetic disorders are caused by gene mutations, which can be found in almost every cell in the body. As a result, these diseases affect a variety of physiological systems and the vast majority of them are incurable. Gene therapy has been utilized to cure a few ailments; however, most therapeutic approaches for genetic conditions do not change the underlying genetic abnormality. Changing a person's DNA to prevent or treat an illness is a novel approach.

Gene therapy with lentiviral vectors is a method of inserting, modifying, or deleting genes in organisms using lentivirus to cure genetic problems. As a result, future expansion of the market will be driven by the use of lentiviral vectors for the treatment of genetic disorders.

Key Takeaways from Market Study

Kits, a subgroup of the product segment, are widely used than reagents and consumables in terms of volume. The segment held 71.7% market share by value in 2021.
Lentiviral vectors are mostly used for the treatment of cancer. The cancer segment, by indication, accounted for a market share of around 65.4% in 2021, which is the highest of all measured across the market.
Academic and research institutes are focused on the development of various new treatment options based on lentiviral vectors for the treatment of various genetic, infectious, and other disorders. Thus, academic and research institutes held the highest market share of 49.1% by value in 2021.
The North America lentiviral vectors market accounted for 35.5% of the global market share in 2021. This is due to the presence of major key players in this region.

"Growing demand for lentiviral vectors, rise in prevalence of infectious diseases, and increasing burden of genetic disorders will drive growth of the lentiviral vectors market over the coming years," says an analyst of Persistence Market Research.

 Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/33074

Market Competition

Key suppliers of lentiviral vectors are focused on strategic collaborations and acquisitions to increase their market share value.

SIRION Biotech, for example, established a collaboration with the Centre for Genomic Regulation in February 2022 to invent a new version of AAV vectors for type 1 and type 2 diabetic gene therapy.
In April 2022, Charles River announced the acquisition of Explora BioLabs.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the lentiviral vectors market in its latest study, presenting a historical demand assessment of 2017 - 2021 and projections for 2022 - 2032.

The research study is based on the products (kits [lentiviral packing systems, lentiviral expression systems, lentiviral promoter kits, and lentiviral fusion tags], reagents & consumables), indication (cancer, genetic disorders, infectious diseases, veterinary diseases, and others), and end user (biotechnology companies, pharmaceutical companies, contract research organizations (CROs), and academic and research institutes), across seven key regions of the world.

Request Customization @ https://www.persistencemarketresearch.com/request-customization/33074

Key Questions Answered in This Report.

What are the Roadblocks for Lentiviral Vectors Market Suppliers?
What are the Key Opportunities for Lentiviral Vectors Market Manufacturers?
How is Focus on Safety Influencing Lentiviral Vectors Market Demand?
What is the Regulatory Impact on Global Sales of Lentiviral Vectors Market?
Which Region Offers the Largest Opportunity for Sales of Lentiviral Vectors Market?
Where Does the U.S. Stand in the Market for Lentiviral Vectors Market?
What Is the Outlook for Lentiviral Vectors Market Manufacturers in China?
Why is Germany a Lucrative Market for Lentiviral Vectors Market Manufacturers?
Why Will Belgium Outpace Other European Markets for Lentiviral Vectors Market?
Why is There High Demand for Tires in Lentiviral Vectors Market?
Why are Sales of Lentiviral Vectors Market Surging?

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.